In Treatment of Angina (heart-related chest pain) Angina is chest pain or discomfort that happens when there is not enough oxygen-rich blood going to part of your heart. This can occur when the blood vessels of the heart become narrow. Flavezee 35 SR Tablet relaxes the blood vessels so that blood can flow more easily and makes sure that your heart is getting a good supply of oxygen. This makes it less likely that you will suffer chest pain caused by angina. Flavezee 35 SR Tablet can also help increase your ability to exercise and lead your daily life more easily by reducing the frequency of angina attacks. You should take it regularly and as long as it is prescribed for it to work effectively. Research shows that the frequency of angina attacks reduces significantly after 6 months of treatment with Flavezee 35 SR Tablet.
Flavezee 35 SR Tablet may cause excessive drowsiness with alcohol.
Information regarding the use of Flavezee 35 SR Tablet during pregnancy is not available. Please consult your doctor.
Information regarding the use of Flavezee 35 SR Tablet during breastfeeding is not available. Please consult your doctor.
Flavezee 35 SR Tablet may decrease alertness, affect your vision or make you feel sleepy and dizzy. Do not drive if these symptoms occur.
Flavezee 35 SR Tablet should be used with caution in patients with kidney disease. Dose adjustment of Flavezee 35 SR Tablet may be needed. Please consult your doctor. Use of Flavezee 35 SR Tablet is not recommended in patients with severe kidney disease.
There is limited information available on the use of Flavezee 35 SR Tablet in patients with liver disease. Please consult your doctor.
If you miss a dose of Flavezee 35 SR Tablet, take it as soon as possible. However, if it is almost time for your next dose, skip the missed dose and go back to your regular schedule. Do not double the dose.
FDC Ltd | B-8, MIDC Area, Waluj - 431 136, Dist. Aurangabad, Maharashtra
Marketer/Manufacturer: Abbott || ₹14.5/tablet (25% cheaper)
No customer reviews yet.
FDA approved prescribing information. Levocitrizine; 1995 [revised May 2007]. [Accessed 01 Apr. 2019] (online) Available from: Read More
European Medicne Agency. Revised assessment report: Ambroxol and bromhexine containing medicinal products. 2015. [Accessed 01 Apr. 2019] (online) Available from: Read More
ScienceDirect. Ambroxol. [Accessed 01 Apr. 2019] (online) Available from: Read More
Levocitrizine. Slough, Berkshire: UCB Pharma Limited; 2007 [revised 27 Mar. 2019]. [Accessed 01 Apr. 2019] (online) Available from: Read More
Marketer/Manufacturer: Shinto Organics (P) Limited || ₹14.5/tablet (25% cheaper)
Marketer/Manufacturer: Accilex Diacardo || ₹14.5/tablet (25% cheaper)
Marketer/Manufacturer: Synmedic Laboratories || ₹14.5/tablet (25% cheaper)
Marketer/Manufacturer: Siochem Pharma Pvt Ltd || ₹14.5/tablet (25% cheaper)
Marketer/Manufacturer: Minova Life Sciences Pvt Ltd || ₹14.5/tablet (25% cheaper)
Marketer/Manufacturer: Raymedica Pharmaceuticals || ₹14.5/tablet (25% cheaper)
Marketer/Manufacturer: Sarvagunaushdhi Pvt Ltd || ₹14.5/tablet (25% cheaper)
Marketer/Manufacturer: Zodley Pharmaceuticals Pvt Ltd || ₹14.5/tablet (25% cheaper)
Marketer/Manufacturer: Micro Labs Ltd || ₹14.5/tablet (25% cheaper)
Marketer/Manufacturer: Abbott || ₹14.5/tablet (25% cheaper)